For best viewing of the website please use Mozilla Firefox or Google Chrome.
Volume 33 Issue 5
October 2018
Article Contents
Citation: Bangyao Sun, Lijia Jia, Bilin Liang, Quanjiao Chen, Di Liu. Phylogeography, Transmission, and Viral Proteins of Nipah Virus [J].VIROLOGICA SINICA, 2018, 33(5) : 385-393.  http://dx.doi.org/10.1007/s12250-018-0050-1

Phylogeography, Transmission, and Viral Proteins of Nipah Virus

  • Corresponding author: Di Liu, liud@wh.iov.cn
  • ORCID: 0000-0003-3693-2726; 
  • Received Date: 14 June 2018
    Accepted Date: 05 September 2018
    Published Date: 11 October 2018
  • Nipah virus (NiV), a zoonotic paramyxovirus belonging to the genus Henipavirus, is classified as a Biosafety Level-4 pathogen based on its high pathogenicity in humans and the lack of available vaccines or therapeutics. Since its initial emergence in 1998 in Malaysia, this virus has become a great threat to domestic animals and humans. Sporadic outbreaks and person-to-person transmission over the past two decades have resulted in hundreds of human fatalities. Epidemiological surveys have shown that NiV is distributed in Asia, Africa, and the South Pacific Ocean, and is transmitted by its natural reservoir, Pteropid bats. Numerous efforts have been made to analyze viral protein function and structure to develop feasible strategies for drug design. Increasing surveillance and preventative measures for the viral infectious disease are urgently needed.
  • 加载中
    1. Albariño CG, Foltzer M, Towner JS, Rowe LA, Campbell S, Jaramillo CM, Bird BH, Reeder DM, Vodzak ME, Rota P, Metcalfe MG, Spiropoulou CF, Knust B, Vincent JP, Frace MA, Nichol ST, Rollin PE, Ströher U (2014) Novel paramyxovirus associated with severe acute febrile disease, South Sudan and Uganda, 2012. Emerg Infect Dis 20:211-216
        doi: 10.3201/eid2002.131620

    2. Ang BSP, Lim TCC, Wang L (2018) Nipah virus infection. J Clin Microbiol 56:e01875-17

    3. Angeletti S, Presti AL, Cella E, Ciccozzi M (2016) Molecular epidemiology and phylogeny of Nipah virus infection: a mini review. Asian Pac J Trop Med 9:630-634
        doi: 10.1016/j.apjtm.2016.05.012

    4. Arankalle VA, Bandyopadhyay BT, Ramdasi AY, Jadi R, Patil DR, Rahman M, Majumdar M, Banerjee PS, Hati AK, Goswami RP, Neogi DK, Mishra AC (2011) Genomic characterization of Nipah virus, West Bengal, India. Emerg Infect Dis 17:907-909
        doi: 10.3201/eid1705.100968

    5. Bishop KA, Stantchev TS, Hickey AC, Khetawat D, Bossart KN, Krasnoperov V, Gill P, Feng YR, Wang L, Eaton BT (2007) Identification of Hendra virus G glycoprotein residues that are critical for receptor binding. J Virol 81:5893-5901
        doi: 10.1128/JVI.02022-06

    6. Bonaparte MI, Dimitrov AS, Bossart KN, Crameri G, Mungall BA, Bishop KA, Choudhry V, Dimitrov DS, Wang LF, Eaton BT (2005) Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus. Proc Natl Acad Sci U S A 102:10652-10657
        doi: 10.1073/pnas.0504887102

    7. Bossart KN, Wang LF, Flora MN, Chua KB, Lam SK, Eaton BT, Broder CC (2002) Membrane fusion tropism and heterotypic functional activities of the Nipah virus and Hendra virus envelope glycoproteins. J Virol 76:11186-11198
        doi: 10.1128/JVI.76.22.11186-11198.2002

    8. Bowden TA, Aricescu AR, Gilbert RJ, Grimes JM, Jones EY, Stuart DI (2008) Structural basis of Nipah and Hendra virus attachment to their cell-surface receptor ephrin-B2. Nat Struct Mol Biol 15:567-572
        doi: 10.1038/nsmb.1435

    9. Breed AC, Meers J, Sendow I, Bossart KN, Barr JA, Smith I, Wacharapluesadee S, Wang L, Field HE (2013) The distribution of henipaviruses in Southeast Asia and Australasia: Is Wallace's line a barrier to Nipah virus? PLoS ONE 8:e61316
        doi: 10.1371/journal.pone.0061316

    10. Breed AC, Yu M, Barr JA, Crameri G, Thalmann CM, Wang LF (2010) Prevalence of henipavirus and rubulavirus antibodies in pteropid bats, Papua New Guinea. Emerg Infect Dis 16:1997-1999
        doi: 10.3201/eid1612.100879

    11. Broder CC, Weir DL, Reid PA (2016) Hendra virus and Nipah virus animal vaccines. Vaccine 34:3525-3534
        doi: 10.1016/j.vaccine.2016.03.075

    12. Bruhn JF, Barnett KC, Bibby J, Thomas JM, Keegan RM, Rigden DJ, Bornholdt ZA, Saphire EO (2014) Crystal structure of the Nipah virus phosphoprotein tetramerization domain. J Virol 88:758-762
        doi: 10.1128/JVI.02294-13

    13. Calisher CH, Childs JE, Field HE, Holmes KV, Schountz T (2006) Bats: important reservoir hosts of emerging viruses. Clin Microbiol Rev 19:531-545
        doi: 10.1128/CMR.00017-06

    14. Centers for Disease Control and Prevention (CDC) (1999a) Update: outbreak of Nipah virus-Malaysia and Singapore, 1999. MMWR Morb Mortal Wkly Rep 48:335-337

    15. Centers for Disease Control and Prevention (CDC) (1999b) Outbreak of Hendra-like virus-Malaysia and Singapore, 1998-1999. MMWR Morb Mortal Wkly Rep 48:265-269

    16. Chadha MS, Comer JA, Luis L, Rota PA, Rollin PE, Bellini WJ, Ksiazek TG, Mishra AC (2006a) Nipah virus-associated encephalitis outbreak, Siliguri, India. Emerg Infect Dis 12:235-240
        doi: 10.3201/eid1202.051247

    17. Chadha MS, Comer JA, Lowe L, Rota PA, Rollin PE, Bellini WJ, Ksiazek TG, Mishra A (2006b) Nipah virus-associated encephalitis outbreak, Siliguri, India. Emerg Infect Dis 12:235-240

    18. Ching PK, de los Reyes VC, Sucaldito MN, Tayag E, ColumnaVingno AB, Malbas FF Jr, Bolo GC Jr, Sejvar JJ, Eagles D, Playford G, Dueger E, Kaku Y, Morikawa S, Kuroda M, Marsh GA, McCullough S, Foxwell AR (2015) Outbreak of henipavirus infection, Philippines, 2014. Emerg Infect Dis 21:328-331
        doi: 10.3201/eid2102.141433

    19. Chong HT, Hossain MJ, Tan CT (2008) Differences in epidemiologic and clinical features of Nipah virus encephalitis between the Malaysian and Bangladesh outbreaks. Neurology Asia 13:23-26

    20. Chua KB, Bellini WJ, Rota PA, Harcourt BH, Tamin A, Lam SK, Ksiazek TG, Rollin PE, Zaki SR, Goldsmith CS (2000) Nipah virus: a recently emergent deadly paramyxovirus. Science 288:1432
        doi: 10.1126/science.288.5470.1432

    21. Clayton BA (2017) Nipah virus: transmission of a zoonotic paramyxovirus. Curr Opin Virol 22:97-104
        doi: 10.1016/j.coviro.2016.12.003

    22. Clayton BA, Marsh GA (2014) Nipah viruses from Malaysia and Bangladesh: Two of a kind? Future Virol 9:935-946
        doi: 10.2217/fvl.14.74

    23. Clayton BA, Middleton D, Bergfeld J, Haining J, Arkinstall R, Wang L, Marsh GA (2012) Transmission routes for Nipah virus from Malaysia and Bangladesh. Emerg Infect Dis 18:1983-1993
        doi: 10.3201/eid1812.120875

    24. Clayton BA, Middleton D, Arkinstall R, Frazer L, Wang LF, Marsh GA (2016) The nature of exposure drives transmission of Nipah viruses from Malaysia and Bangladesh in ferrets. Plos Negl Trop Dis 10:e0004775
        doi: 10.1371/journal.pntd.0004775

    25. Cox RM, Plemper RK (2017) Structure and organization of paramyxovirus particles. Curr Opin Virol 24:105-114
        doi: 10.1016/j.coviro.2017.05.004

    26. Daszak P, Cunningham AA, Hyatt AD (2001) Anthropogenic environmental change and the emergence of infectious diseases in wildlife. Acta Trop 78:103-116
        doi: 10.1016/S0001-706X(00)00179-0

    27. Diederich S, Maisner A (2007) Molecular characteristics of the Nipah virus glycoproteins. Ann N Y Acad Sci 1102:39-50
        doi: 10.1196/annals.1408.003

    28. Dietzel E, Kolesnikova L, Sawatsky B, Heiner A, Weis M, Kobinger GP, Becker S, Von MV, Maisner A (2015) Nipah virus matrix protein influences fusogenicity and is essential for particle infectivity and stability. J Virol 90:2514-2522

    29. Enchéry F, Horvat B (2017) Understanding the interaction between henipaviruses and their natural host, fruit bats: paving the way toward control of highly lethal infection in humans. Int Rev Immunol 36:108-121
        doi: 10.1080/08830185.2016.1255883

    30. Epstein JH, Field HE, Luby S, Pulliam JR, Daszak P (2006) Nipah virus: impact, origins, and causes of emergence. Curr Infect Dis Rep 8:59-65
        doi: 10.1007/s11908-006-0036-2

    31. Field H, de Jong CE, Halpin K, Smith CS (2013) Henipaviruses and fruit bats, Papua New Guinea. Emerg Infect Dis 19:670-671
        doi: 10.3201/eid1904.111912

    32. Goh KJ, Tan CT, Chew NK, Tan PSK, Kamarulzaman A, Sarji SA, Wong KT, Abdullah BJJ, Chua KB, Lam SK (2000) Clinical features of Nipah virus encephalitis among pig farmers in Malaysia. N Engl J Med 342:1229-1235
        doi: 10.1056/NEJM200004273421701

    33. Gurley ES, Montgomery JM, Hossain MJ, Bell M, Azad AK, Islam MR, Molla MA, Carroll DS, Ksiazek TG, Rota PA, Lowe L, Comer JA, Rollin P, Czub M, Grolla A, Feldmann H, Luby SP, Woodward JL, Breiman RF (2007) Person-to-person transmission of Nipah virus in a Bangladeshi community. Emerg Infect Dis 13:1031-1037
        doi: 10.3201/eid1307.061128

    34. Habchi J, Longhi S (2012) Structural disorder within paramyxovirus nucleoproteins and phosphoproteins. Mol Biosyst 8:69-81
        doi: 10.1039/C1MB05204G

    35. Halpin K, Hyatt AD, Fogarty R, Middleton D, Bingham J, Epstein JH, Rahman SA, Hughes T, Smith C, Field HE, Daszak P, Henipavirus Ecology Research Group (2011) Pteropid bats are confirmed as the reservoir hosts of henipaviruses: a comprehensive experimental study of virus transmission. Am J Trop Med Hyg 85:946-951
        doi: 10.4269/ajtmh.2011.10-0567

    36. Harcourt BH, Lowe L, Tamin A, Liu X, Bankamp B, Bowden N, Rollin PE, Comer JA, Ksiazek TG, Hossain MJ (2005) Genetic characterization of Nipah virus, Bangladesh, 2004. Emerg Infect Dis 11:1594-1597
        doi: 10.3201/eid1110.050513

    37. Hasebe F, Thuy NTT, Inoue S, Yu F, Kaku Y, Watanabe S, Akashi H, Dat DT, Mai LTQ, Morita K (2012) Serologic evidence of Nipah virus infection in bats, Vietnam. Emerg Infect Dis 18:536-537
        doi: 10.3201/eid1803.111121

    38. Hossain MJ, Gurley ES, Montgomery JM, Bell M, Carroll DS, Hsu VP, Formenty P, Croisier A, Bertherat E, Faiz MA (2008) Clinical presentation of nipah virus infection in Bangladesh. Clin Infect Dis 46:977-984
        doi: 10.1086/587996

    39. Hsu VP, Hossain MJ, Parashar UD, Ali MM, Ksiazek TG, Kuzmin I, Niezgoda M, Rupprecht C, Bresee J, Breiman RF (2004) Nipah virus encephalitis reemergence, Bangladesh. Emerg Infect Dis 10:2082-2087
        doi: 10.3201/eid1012.040701

    40. Hu B, Zeng LP, Yang XL, Ge XY, Zhang W, Li B, Xie JZ, Shen XR, Zhang YZ, Wang N (2017) Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus. PLoS Pathog 13:e1006698
        doi: 10.1371/journal.ppat.1006698

    41. Iehlé C, Razafitrimo G, Razainirina J, Andriaholinirina N, Goodman SM, Faure C, Georges-Courbot MC, Rousset D, Reynes JM (2007) Henipavirus and Tioman virus antibodies in pteropodid bats, Madagascar. Emerg Infect Dis 13:159-161
        doi: 10.3201/eid1301.060791

    42. Khan MSU, Hossain J, Gurley ES, Nahar N, Sultana R, Luby SP (2010) Use of infrared camera to understand bats' access to date palm sap: implications for preventing Nipah virus transmission. EcoHealth 7:517
        doi: 10.1007/s10393-010-0366-2

    43. Lee KE, Umapathi T, Mmed CBT, Chua TS, Oh ML, Frcp KMF, Kurup A, Asha Das MD, Tan KY (1999) The neurological manifestations of Nipah virus encephalitis, a novel paramyxovirus. Ann Neurol 46:428-432
        doi: 10.1002/(ISSN)1531-8249

    44. Lee B, Rota PA, Lee B, Rota PA (2012) Henipavirus: ecology, molecular virology, and pathogenesis. Curr Top Microbiol Immunol 359:Ⅴ-Ⅵ

    45. Li W, Shi Z, Yu M, Ren W, Smith C, Epstein JH, Wang H, Crameri G, Hu Z, Zhang H (2005) Bats are natural reservoirs of SARSlike coronaviruses. Science 310:676-679
        doi: 10.1126/science.1118391

    46. Lo MK, Peeples ME, Bellini WJ, Nichol ST, Rota PA, Spiropoulou CF (2012) Distinct and overlapping roles of Nipah virus P gene products in modulating the human endothelial cell antiviral response. PLoS ONE 7:e47790
        doi: 10.1371/journal.pone.0047790

    47. Lou Z, Xu Y, Xiang K, Su N, Qin L, Li X, Gao GF, Bartlam M, Rao Z (2006) Crystal structures of Nipah and Hendra virus fusion core proteins. FEBS J 273:4538-4547
        doi: 10.1111/ejb.2006.273.issue-19

    48. Luby SP, Rahman M, Hossain MJ, Blum LS, Husain MM, Gurley E, Khan R, Ahmed BN, Rahman S, Nahar N, Kenah E, Comer JA, Ksiazek TG (2006) Foodborne transmission of Nipah virus, Bangladesh. Emerg Infect Dis 12:1888-1894
        doi: 10.3201/eid1212.060732

    49. Mathieu C, Guillaume V, Volchkova VA, Pohl C, Jacquot F, Looi RY, Wong KT, Legras-Lachuer C, Volchkov VE, Lachuer J (2012) Nonstructural Nipah virus C protein regulates both the early host proinflammatory response and viral virulence. J Virol 86:10766-10775
        doi: 10.1128/JVI.01203-12

    50. Michalski WP, Crameri G, Wang LF, Shiell BJ, Eaton B (2000) The cleavage activation and sites of glycosylation in the fusion protein of Hendra virus. Virus Res 69:83-93
        doi: 10.1016/S0168-1702(00)00169-6

    51. Middleton D (2014) Hendra virus. Vet Clin North Am Equine Pract 30:579-589
        doi: 10.1016/j.cveq.2014.08.004

    52. Middleton DJ, Morrissy CJ, Bm VDH, Russell GM, Braun MA, Westbury HA, Halpin K, Daniels PW (2007) Experimental Nipah virus infection in pteropid bats (Pteropus poliocephalus). J Comp Pathol 136:266-272
        doi: 10.1016/j.jcpa.2007.03.002

    53. Ming L, Dong D (2016) Phylogenomic analyses of bat subordinal relationships based on transcriptome data. Sci Rep 6:27726
        doi: 10.1038/srep27726

    54. Moratelli R, Calisher CH (2015) Bats and zoonotic viruses: can we confidently link bats with emerging deadly viruses? Mem Inst Oswaldo Cruz 110:1-22
        doi: 10.1590/0074-02760151

    55. Morin B, Kranzusch PJ, Rahmeh AA, Whelan SP (2013) The polymerase of negative-stranded RNA viruses. Curr Opin Virol 3:103
        doi: 10.1016/j.coviro.2013.03.008

    56. Nahar N, Sultana R, Gurley ES, Hossain MJ, Luby SP (2010) Date palm sap collection: exploring opportunities to prevent Nipah transmission. EcoHealth 7:196-203
        doi: 10.1007/s10393-010-0320-3

    57. Negrete OA, Levroney EL, Aguilar HC, Bertolotticiarlet A, Nazarian R, Tajyar S, Lee B (2005) EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus. Nature 436:401-405
        doi: 10.1038/nature03838

    58. Negrete OA, Wolf MC, Aguilar HC, Enterlein S, Wang W, Mühlberger E, Su SV, Bertolotticiarlet A, Flick R, Lee B (2006) Two key residues in ephrinB3 are critical for its use as an alternative receptor for Nipah virus. PLoS Pathog 2:e7
        doi: 10.1371/journal.ppat.0020007

    59. Paton NI, Leo YS, Zaki SR, Auchus AP, Lee KE, Ling AE, Chew SK, Ang B, Rollin PE, Umapathi T (1999) Outbreak of Nipah-virus infection among abattoir workers in Singapore. Lancet 354:1253-1256
        doi: 10.1016/S0140-6736(99)04379-2

    60. Paul L (2018) Nipah virus in Kerala: a deadly zoonosis. Clin Microbiol Infect. https://doi.org/10.1016/j.cmi.2018.06.017

    61. Pernet O, Schneider BS, Beaty SM, Lebreton M, Yun TE, Park A, Zachariah TT, Bowden TA, Hitchens P, Ramirez CM (2013) Evidence for henipavirus spillover into human populations in Africa. Nat Commun 5:5342

    62. Rahman MA, Hossain MJ, Sultana S, Homaira N, Khan SU, Rahman M, Gurley ES, Rollin PE, Lo MK, Comer JA (2012) Date palm sap linked to Nipah virus outbreak in Bangladesh, 2008. Vector Borne Zoonotic Dis 12:65-72
        doi: 10.1089/vbz.2011.0656

    63. Reynes JM, Counor D, Ong S, Faure C, Seng V, Molia S, Walston J, Georgescourbot MC, Deubel V, Sarthou JL (2005) Nipah virus in Lyle's flying foxes, Cambodia. Emerg Infect Dis 11:1042-1047
        doi: 10.3201/eid1107.041350

    64. Sendow I, Field HE, Adjid A, Ratnawati A, Breed AC, Darminto Morrissy C, Daniels P (2010) Screening for Nipah virus infection in West Kalimantan province, Indonesia. Zoonoses Public Health 57:499-503
        doi: 10.1111/j.1863-2378.2009.01252.x

    65. Supaporn W, Boonlert L, Kalyanee B, Sawai W, Lawan C, Pierre R, Patrick S, Rupprecht CE, Ksiazek TG, Thiravat H (2005) Bat Nipah virus, Thailand. Emerg Infect Dis 11:1949-1951
        doi: 10.3201/eid1112.050613

    66. Tan CT, Tan KS (2001) Nosocomial transmissibility of Nipah virus. J Infect Dis 184:1367
        doi: 10.1086/jid.2001.184.issue-10

    67. Tamin A, Harcourt BH, Ksiazek TG, Rollin PE, Bellini WJ, Rota PA (2002) Functional properties of the fusion and attachment glycoproteins of Nipah virus. Virology 296:190-200
        doi: 10.1006/viro.2002.1418

    68. Wang L, Harcourt BH, Yu M, Tamin A, Rota PA, Bellini WJ, Eaton BT (2001) Molecular biology of Hendra and Nipah viruses. Microbes Infect 3:279-287
        doi: 10.1016/S1286-4579(01)01381-8

    69. Weatherman S, Feldmann H, Wit ED (2018) Transmission of henipaviruses. Curr Opin Virol 28:7-11
        doi: 10.1016/j.coviro.2017.09.004

    70. Wit ED, Munster VJ (2015) Nipah virus emergence, transmission, and pathogenesis. Springer, New York

    71. Wit ED, Prescott J, Falzarano D, Bushmaker T, Scott D, Feldmann H, Munster VJ (2014) Foodborne transmission of Nipah virus in syrian hamsters. PLoS Pathog 10:e1004001
        doi: 10.1371/journal.ppat.1004001

    72. Xu Y, Lou Z, Liu Y, Cole DK, Su N, Qin L, Li X, Bai Z, Rao Z, Gao GF (2004) Crystallization and preliminary crystallographic analysis of the fusion core from two new zoonotic paramyxoviruses, Nipah virus and Hendra virus. Acta Crystallogr D Biol Crystallogr 60:1161-1164
        doi: 10.1107/S0907444904009515

    73. Xu K, Rajashankar KR, Chan YP, Himanen JP, Broder CC, Nikolov DB (2008) Host cell recognition by the henipaviruses: crystal structures of the Nipah G attachment glycoprotein and its complex with ephrin-B3. Proc Natl Acad Sci U S A 105:9953-9958
        doi: 10.1073/pnas.0804797105

    74. Xu K, Chan YP, Birgit BT, Zeynep AA, Zhu Y, Somnath D, Yan L, Feng YR, Wang LF, Georgios S (2015) Crystal structure of the pre-fusion Nipah virus fusion glycoprotein reveals a novel hexamer-of-trimers assembly. PLoS Pathog 11:e1005322
        doi: 10.1371/journal.ppat.1005322

    75. Yabukarski F, Lawrence P, Tarbouriech N, Bourhis JM, Delaforge E, Jensen MR, Ruigrok RW, Blackledge M, Volchkov V, Jamin M (2014) Structure of Nipah virus unassembled nucleoprotein in complex with its viral chaperone. Nat Struct Mol Biol 21:754-759
        doi: 10.1038/nsmb.2868

    76. Yan L, Wang J, Hickey AC, Zhang Y, Li Y, Yi W, Zhang H, Yuan J, Han Z, Jennifer ME (2008) Antibodies to Nipah or Nipah-like viruses in bats, China. Emerg Infect Dis 14:1974-1976
        doi: 10.3201/eid1412.080359

    77. Zhou P, Fan H, Lan T, Yang XL, Shi WF, Zhang W, Zhu Y, Zhang YW, Xie QM, Mani S, Zheng XS, Li B, Li JM, Guo H, Pei GQ, An XP, Chen JW, Zhou L, Mai KJ, Wu ZX, Li D, Anderson DE, Zhang LB, Li SY, Mi ZQ, He TT, Cong F, Guo PJ, Huang R, Luo Y, Liu XL, Chen J, Huang Y, Sun Q, Zhang XL, Wang YY, Xing SZ, Chen YS, Sun Y, Li J, Daszak P, Wang LF, Shi ZL, Tong YG, Ma JY (2018) Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin. Nature 556:255-258
        doi: 10.1038/s41586-018-0010-9

  • 加载中

Figures(6)

Article Metrics

Article views(554) PDF downloads(4) Cited by()

Ralated
Proportional views
    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Phylogeography, Transmission, and Viral Proteins of Nipah Virus

      Corresponding author: Di Liu, liud@wh.iov.cn
    • 1. Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China
    • 2. University of Chinese Academy of Sciences, Beijing 100049, China

    Abstract: Nipah virus (NiV), a zoonotic paramyxovirus belonging to the genus Henipavirus, is classified as a Biosafety Level-4 pathogen based on its high pathogenicity in humans and the lack of available vaccines or therapeutics. Since its initial emergence in 1998 in Malaysia, this virus has become a great threat to domestic animals and humans. Sporadic outbreaks and person-to-person transmission over the past two decades have resulted in hundreds of human fatalities. Epidemiological surveys have shown that NiV is distributed in Asia, Africa, and the South Pacific Ocean, and is transmitted by its natural reservoir, Pteropid bats. Numerous efforts have been made to analyze viral protein function and structure to develop feasible strategies for drug design. Increasing surveillance and preventative measures for the viral infectious disease are urgently needed.

    • In February 2018, Nipah Virus (NiV) infection was listed as a priority disease posing a public health risk by the World Health Organization (http://www.who.int/blueprint/en/). NiV was named after Kampung Sungai Nipah (Nipah River Village) in Malaysia, where it was first isolated in 1998, before its subsequent spread into Singapore via exported pigs in 1999, leading to the abattoir worker infections (CDC 1999a, b; Paton et al. 1999; Epstein et al. 2006). In 2001, human cases of NiV infection were discovered independently in India and Bangladesh, and since then, infections have been observed annually in Bangladesh, and human-to-human transmission through direct contact with infected individuals is common (Hsu et al. 2004; Chadha et al. 2006a, b). In 2007, an NiV outbreak occurred in India, killing five people (Arankalle et al. 2011). In 2018, NiV infection was ongoing in Kerala, India, with 16 cases succumbed (Paul 2018). In 2014, a serious illness most probably caused by NiV was reported in several people after contact with infected horses or patients in the Philippines (Ching et al. 2015). NiV infection can cause fever and encephalitis in humans and a neurological and respiratory syndrome in pigs or horses (Lee et al. 1999; CDC 1999a, b). To date, over 600 human cases of NiV infection have been reported in South Asia and South-East Asia, with fatality ranging from 40% to 70%, accordingly it poses a major threat to human health (Clayton 2017).

      Belonging to the genus Henipavirus [the other pathogenic member of the genus is Hendra virus (HeV), reviewed in (Middleton 2014; Enchéry and Horvat 2017)] of the family Paramyxoviridae (Chua et al. 2000), NiV is classified as a Biosafety Level-4 (BSL-4) pathogen due to its high pathogenicity and the lack of any effective treatments or vaccines (Wit and Munster 2015; Angeletti et al. 2016). The NiV genome consists of a negative-sense, single-stranded RNA of approximately 18.2 kb, encoding six structural proteins, nucleoprotein (N), phosphoprotein (P), matrix protein (M), fusion protein (F), attachment glycoprotein (G), and the large protein or RNA polymerase protein (L). In addition, the P gene encodes three nonstructural proteins by RNA editing (V and W proteins) or an alternative open reading frame (C protein) (Wang et al. 2001) (Fig. 1).

      Figure 1.  Schematic representation of the viral structure (upper panel) and genome organization (lower panel). Different genes or proteins are indicated in different colors.

      NiV has a wide range of hosts, from its natural reservoir Pteropid bats to humans, horses, dogs, cats, cows, and pigs (Calisher et al. 2006; Halpin et al. 2011; Weatherman et al. 2018). Close contact with infected patients (Tan and Tan 2001) or domestic animals (e.g., pigs and horses) plays an important role in the spread of NiV (Clayton 2017). Furthermore, palm sap is also currently regarded as a crucial NiV transmission medium in Bangladesh (Luby et al. 2006; Nahar et al. 2010; Rahman et al. 2012). Intraspecific transmission (in bats, pigs, and horses) is also possible via saliva, urine or secretions upon high density populations of animals (Middleton et al. 2007; Weatherman et al. 2018). In this review, an overview of recent studies on the geographical and phylogenetic properties, transmission, and protein structure and function of NiV is provided.

    • Since it emerged in Malaysia in 1998, NiV caused a series of outbreaks in Singapore, India, and Bangladesh (Clayton 2017; Enchéry and Horvat 2017) (Fig. 2), which has caused hundreds of human deaths and thereby represents a great challenge to public health. Numerous efforts have been made to trace the origin, distribution, and probable transmission route of NiV in nature. For example, in Bangladesh, where humans are frequently infected by NiV, retrospective investigations combined with the collect of biological samples from patients or contaminated environment have been conducted to evaluate potential risk factors and to develop a feasible strategy for prevention and control (Hsu et al. 2004; Gurley et al. 2007; Rahman et al. 2012). Additionally, NiV surveillance in areas where no NiV outbreaks have been reported is ongoing. Extensive studies and sample collections (swabs, sera, saliva, and urine) and analyses from bats have indicated that in addition to the countries where NiV outbreaks have occurred, NiV is also distributed in China (Yan et al. 2008), Vietnam (Hasebe et al. 2012), Thailand (Supaporn et al. 2005), Cambodia (Reynes et al. 2005), Indonesia (Sendow et al. 2010), East Timor (Breed et al. 2013), Madagascar (Iehlé et al. 2007), New Caledonia (Enchéry and Horvat 2017) and Papua New Guinea (Breed et al. 2010; Field et al. 2013) (Fig. 2). In addition, anti-NiV neutralization antibody test of the serum from people involved in hunting bats as bushmeat revealed evidence of NiV spillover (Pernet et al. 2013), which emphasizes the significance of further NiV monitoring.

      Figure 2.  Summary of the known geographical distribution of Nipah virus in the world. Yellow stars represent reported Nipah virus outbreaks and green star shows the likely presence of Nipah-like virus.

    • Understanding susceptible hosts and routes for the spread of viral disease raises knowledge to curb epidemics. Bats are the second largest order of mammals after rodents (Moratelli and Calisher 2015; Ming and Dong 2016), and harbor in excess of 200 types of viruses, including many highly pathogenic to humans (e.g., rabies, Ebola, severe acute respiratory syndrome (SARS), NiV, HeV) (Li et al. 2005; Calisher et al. 2006). NiV circulates within bat populations via close mutual contact when bats crowd together (Middleton et al. 2007). NiV transmission from bats to humans is through two main pathways, i.e., intermediate hosts (pigs and horses) and food-borne transmission via date palm sap contaminated with the saliva or urine of fruit bats (Enchéry and Horvat 2017) [reviewed in (Clayton 2017)]. A retrospective study in Malaysia found that workers show severe influenza-like symptoms after slaughtering NiV-infected swine (Hsu et al. 2004). In the Philippines, people were infected by butchering horses or consuming horsemeat (Ching et al. 2015). No cases of person-to-person spread have been found in Malaysia or Singapore, but in the Philippines, direct human-to-human virus transmission has been reported (Ching et al. 2015). In India, human-to-human transmission of NiV was discovered in 2001. In a case of NiV infection in a human in 2007, date palm sap contaminated by bats was considered to mediate NiV spillover from bats to humans (Chadha et al. 2006a, 2006b; Arankalle et al. 2011). In Bangladesh, where people consume palm sap, frequent infection by NiV and person-to-person NiV transmission has occurred. Recently, it was demonstrated that Syrian hamster infection could occur after drinking artificial palm sap mixed with NiV (Wit et al. 2014) and infrared camera monitoring showed that bats frequently fly around or directly contact palm sap trees to urinate or defecate (Khan et al. 2010; Rahman et al. 2012). These findings provide further support for palm sap-mediated bat-to-person transmission, despite the lack of Nipah virus detection in natural date palm sap until now (Fig. 3). Measures have been taken to prevent bat access to sap using bamboo skirts or lime smudged on date palm trees. Further steps to prevent the transmission of NiV infection are necessary.

      Figure 3.  Schematic representation of transmission routes for Nipah virus. In Malaysia, the fruit trees where fruit bats reside are in proximity to pig farms and domestic pigs infected by NiV via contact with materials contaminated by bats, and NiV is subsequently transmitted to humans by direct contact. In India or Bangladesh, persons infected by NiV after consuming the date palm sap contaminated by bat saliva or urine, followed by person-to-person transmission by close contact. In the Philippines, people were infected by consuming horsemeat or contact with infected horses, and then healthy individuals were infected after contact with patients.

    • Genomic and amino acid differences may explain differences in viral pathogenicity and virulence between isolates in Bangladesh and Malaysia, particularly given the contributions of the N, P and L proteins to viral replication and transcription and the role of the nonstructural protein C in the virulence of NiV (see "Viral Protein Function and Structure" section). In sequence analyses (Harcourt et al. 2005), nucleotide sequence identity between the genomes of NiV-Bangladesh and NiV-Malaysia was only 91.8%, with an uneven distribution of differences throughout the genome. The amino acid sequence identity between NiV-Bangladesh and NiV-Malaysia proteins were all greater than 92%. Furthermore, the nucleotide sequence identity of N, P, L, and C genes were 94.3%, 92.0%, 93.4%, and 97.6%, respectively, with corresponding amino acid sequence identity of 98.3%, 92%, 98.2%, and 95.2%, respectively (Harcourt et al. 2005) (Fig. 4A). These findings provided a basis for further investigations of the biological characteristics of NiV.

      Figure 4.  Genomic and phylogenetic analyses of Nipah virus. A Comparisons of both nucleotide sequence and amino acid sequence identity between NiV-Bangladesh and NiV-Malaysia. B Maximum clade credibility (MCC) tree of Nipah virus genomes. The tree was performed by using BEAST package 2.4.8 with the HKY SRD06 model, under an uncorrelated relaxed clock, and the exponential growth demographic model. NiV-Bangladesh is represented in pink and NiV-Malaysia is in brown. The purple bars represent the 95% highest posterior density intervals of the estimation of the dates.

      Based on the time-scaled tree constructed using the currently available viral genomes, the time to the most recent common ancestor (tMRCA) of NiV could be dated to 1356 (95% highest posterior density, 95% HPD: 482—1884). The strains were divided into two lineages (NiV-Bangladesh, n = 4, and NiV-Malaysia, n = 11), with different clinical features and transmission routes in Bangladesh and Malaysia (Fig. 4B). Due to the limited viral genomes available, the detailed divergent time of Bangladesh and Malaysia lineages needs further investigation. More frequent person-to-person contact and more severe respiratory disease have been observed in Bangladesh than in Malaysia (Goh et al. 2000; Chong et al. 2008; Hossain et al. 2008), consistent with the higher level of viral replication in ferrets for NiV-Bangladesh than NiV-Malaysia (Clayton et al. 2012). However, a recent study suggested that social and environmental factors impact the spread of NiV (Clayton and Marsh 2014; Clayton et al. 2016). In Malaysia, no person-to-person transmission was reported when NiV emerged in 1998 and NiV strains derived from humans were isolated in 1999-2000 (Fig. 4B), whereas, in Bangladesh, NiV has appeared nearly annually since 2001 along with significant human-to-human transmission. Thus, comparative genomics and reverse genetics approaches are required to uncover the different features between NiV-Bangladesh and NiV-Malaysia.

    • Nipah virus has an approximately 18.2 kb genome encoding six structural proteins and three nonstructural proteins. The viral ribonucleocapsid (RNP) surrounded by the viral envelope consists of its genome and the N protein, which is essential for the viral life cycle as a template for RNA-dependent RNA-polymerase (RdRp), composed of polymerase L and a polymerase cofactor P (Diederich and Maisner 2007; Cox and Plemper 2017). Within the RNP, N is responsible for viral genome wrapping and facilitates viral replication and transcription (Lee et al. 2012). The synthesis of viral mRNA is catalyzed by L and P (Morin et al. 2013), and the latter also inhibits interferon signaling via host STAT-1 (Lo et al. 2012) and acts as a chaperone of N0 (the unassembled form of N) to prevent it nonspecific binding to host RNA (Habchi and Longhi 2012). The M protein contributes to viral assembly and release (Dietzel et al. 2015). G and F are two important surface glycoproteins of NiV; the former induces viral attachment to two cellular receptors, ephrin-B2 and ephrin-B3, despite a lack of hemagglutination or neuraminidase activity (Bonaparte et al. 2005; Negrete et al. 2005, 2006; Bishop et al. 2007). And this subsequently triggers F-mediated membrane fusion between virus and host cells (Bossart et al. 2002; Tamin et al. 2002). The nonstructural protein C participates in the host immune response and serves as a virulence factor (Mathieu et al. 2012).

      Elucidating the viral structure is regarded as a promising approach for antiviral drug design, and several crystal structures of NiV proteins have been reported. The crystal structure of the P protein is a tetramer with a parallel coiled coil (Fig. 5A), while the N0-P complex, whose binding site is located in residues 1-50 (P50) of the N-terminal domain of P, is characterized by an asymmetric pea-like form composed of three heterodimers. N0 remains an open conformation in the complex due to P-mediated inhibition of the polymerization of N (Bruhn et al. 2014; Yabukarski et al. 2014) (Fig. 5B).

      Figure 5.  Crystal structures of P and the N0-P complex. A Cartoon representation of NiV-P (Protein Data Bank accession number 4N5B). Four chains are indicated in four different colors. N and C termini are shown. B Structure of three heterodimers of the N0-P complex (PDB: 4CO6). P50 is shown in cyan and N0 is in green.

      The extracellular region of the attachment glycoprotein G, which is a tetrameric type Ⅱ membrane protein, is a disk-like β-propeller with six blades (B1-B6) encircling the center in its receptor-unbound status and changes its form in the G/Ephrin-B3 complex. Each blade module in the β-propeller enhanced by a disulfide bond (C181-C601) contains a four-stranded (strands S1-S4) antiparallel β-sheet (Fig. 6A). The structure of the G/Ephrin-B3 complex is elongated with a heterodimeric assembly compared to G (Xu et al. 2008). Ephrin-B3 attaches to the upper face of the G β-propeller and their interaction is mediated by several G loops, including B1S2-B1S3, B3H2-B3H3, B4S4-B5S1, and B5S2-B5S3 (Fig. 6B). The crystal structure of the G/Ephrin-B2 complex is characterized by a capacious protein-protein interface containing crucial residues 107-125 on Ephrin-B2 (Bowden et al. 2008) (Fig. 6C). F, a typical trimeric class Ⅰ membrane protein, is synthesized as an immature precursor (called F0) and is then cleaved by cellular protease into F1 and F2 subunits linked by a disulfide bond. Two heptad-repeat regions (HR1 and HR2) in F1 contribute to the membrane merger (Michalski et al. 2000; Tamin et al. 2002). In the pre-fusion form of the ectodomain of F, six copies of F trimers assemble a hexamer around a central axis (Xu et al. 2015), which confers the stability of pre-fusion F (Fig. 6D). During subsequent membrane fusion, the conformation of two HR domains changes and a six-helix bundle, called a fusion core, takes shape to facilitate viral penetration after the merger, characterized by three parallel HR1 domains surrounded by three anti-parallel HR2 domains (Xu et al. 2004; Lou et al. 2006) (Fig. 6E). Given that only supportive treatments are available in hospital setting for NiV [detailed information about viral tropism, vaccines and antiviral strategies of NiV was reviewed in references (Broder et al. 2016; Ang et al. 2018)], these results provide potential targets for drug or vaccine design.

      Figure 6.  Crystal structures of G and F protein. A Cartoon representation of NiV-G (PDB: 3D11) in the receptor-unbound state. Six blades are represented as follows: B1 in red, B2 in green, B3 in yellow, B4 in cyan, B5 in gray and B6 in magenta. N and C termini are shown in the figure. The disulfide bond (C181-C601) is not shown. B Structure of the G/Ephrin-B3 complex (PDB: 3D12). The upper Ephrin-B3 is labeled in cyan and the lower G is in green. Four G loops are indicated as following, B1S2-B1S3 in red, B3H2-B3H3 in blue, B4S4-B5S1 in magenta, and B5S2-B5S3 in orange. C An overview of the G/Ephrin-B2 complex structure (PDB: 2VSM). NiV-G and Ephrin-B2 are shown in green and cyan, respectively, and residues 107-125 is in green. D The structure of NiV-F pre-fusion (PDB: 5EVM). Three chains of F trimers are indicated in green, yellow, and cyan, and the hexamer form of F trimers is not represented. E Cartoon representation of the fusion core (PDB: 1WP7). HR1 is indicated in green and HR2 is in lemon with N and C termini.

    • Knowing the geographic distribution and transmission of a virus is the priority for the control of infection and resolving the structure and function of viral protein is the basis for anti-viral drug development. In this review, we are focusing on these aspects of the NiV. As a huge natural reservoir of viruses, including NiV, bats have been under renewed interest. Bats appear asymptomatic when infected by many viruses and play a pivotal role in viral spillover. Continually emerging and reemerging viruses from bats have been reported. In 2012, a novel rubula-like paramyxovirus from fruit bats was found to be responsible for a series of severe clinical symptoms appearing on a female wildlife biologist who performed a 6-week field exploration in South Sudan and Uganda (Albariño et al. 2014). In 2017, a huge gene pool of SARS-like coronaviruses was found in horseshoe bats in a cave in Yunnan province, China, which indicated the close relationship between those isolates and SARS coronavirus (Hu et al. 2017). Recently, a novel bat-originated coronavirus, swine acute diarrhea syndrome coronavirus (SADS-CoV), which led to more than 24, 000 piglet deaths at four pig farms in Guangdong province, China was reported (Zhou et al. 2018). In particular, a similar transmission pathway between SADS-CoV and NiV (bats to pigs) occurs, although no human infection was found. More exposure to areas of bat movement augments extremely risk of infecting bat-derived viral diseases. Unfortunately, human activities are altering the frequency of contact with bats. For instance, deforestation in tropical zones forces bats to migrate from their habitats to human areas (Daszak et al. 2001) and many bats are hunted for consumption or so-called harmfulness (Enchéry and Horvat 2017). Therefore, continuous surveillance, reducing human activities that promote contact with bats, and enhancing scientific research will help the prevention and control of bat-derived viral infectious disease. Given limited viral genomes available, restrictions on investigating the origin and evolution of Nipah virus have been imposed; therefore, continuous epidemiological surveillance must be strengthened in the future. In addition, several structures of viral proteins remain unknown; accordingly, it is necessary to increase basic research efforts on protein structures and functional analyses of viral proteins to provide data for antiviral drug and vaccine development.

    • This work was supported by National Key Research and Development Program (2016YFC1200800) and Advanced Customer Cultivation Project of Wuhan National Biosafety Laboratory, Chinese Academy of Sciences.

    • The authors declare that they have no conflict of interest.

    • This article does not contain any studies with human or animal subjects performed by any of the authors.

    • This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

    Figure (6)  Reference (77) Relative (20)

    目录

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return